nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0602	0.137	CbGbCtD
Niacin—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0566	0.129	CbGbCtD
Niacin—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0566	0.129	CbGbCtD
Niacin—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0512	0.116	CbGbCtD
Niacin—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0512	0.116	CbGbCtD
Niacin—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0442	0.1	CbGbCtD
Niacin—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0429	0.0974	CbGbCtD
Niacin—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0388	0.0881	CbGbCtD
Niacin—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0388	0.0881	CbGbCtD
Niacin—HCAR3—blood—acquired immunodeficiency syndrome	0.00816	0.0675	CbGeAlD
Niacin—HCAR3—lung—acquired immunodeficiency syndrome	0.00715	0.0592	CbGeAlD
Niacin—HCAR2—skin of body—acquired immunodeficiency syndrome	0.0071	0.0587	CbGeAlD
Niacin—HCAR2—lymphoid tissue—acquired immunodeficiency syndrome	0.00575	0.0475	CbGeAlD
Niacin—HCAR2—blood—acquired immunodeficiency syndrome	0.00541	0.0447	CbGeAlD
Niacin—QPRT—nervous system—acquired immunodeficiency syndrome	0.00524	0.0433	CbGeAlD
Niacin—QPRT—central nervous system—acquired immunodeficiency syndrome	0.00504	0.0417	CbGeAlD
Niacin—HCAR2—lung—acquired immunodeficiency syndrome	0.00474	0.0392	CbGeAlD
Niacin—QPRT—brain—acquired immunodeficiency syndrome	0.004	0.0331	CbGeAlD
Niacin—HCAR2—lymph node—acquired immunodeficiency syndrome	0.00324	0.0268	CbGeAlD
Niacin—NNMT—digestive system—acquired immunodeficiency syndrome	0.00319	0.0264	CbGeAlD
Niacin—SLC16A3—retina—acquired immunodeficiency syndrome	0.00311	0.0257	CbGeAlD
Niacin—NNMT—bone marrow—acquired immunodeficiency syndrome	0.00294	0.0243	CbGeAlD
Niacin—NNMT—spinal cord—acquired immunodeficiency syndrome	0.00293	0.0242	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00289	0.0338	CbGpPWpGaD
Niacin—NNMT—vagina—acquired immunodeficiency syndrome	0.00282	0.0233	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00274	0.032	CbGpPWpGaD
Niacin—NNMT—lung—acquired immunodeficiency syndrome	0.00267	0.0221	CbGeAlD
Niacin—NNMT—nervous system—acquired immunodeficiency syndrome	0.00247	0.0204	CbGeAlD
Niacin—NNMT—central nervous system—acquired immunodeficiency syndrome	0.00238	0.0197	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0022	0.0257	CbGpPWpGaD
Niacin—SLC16A3—digestive system—acquired immunodeficiency syndrome	0.00218	0.018	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00208	0.0244	CbGpPWpGaD
Niacin—SLC16A3—blood—acquired immunodeficiency syndrome	0.00208	0.0172	CbGeAlD
Niacin—SLCO2B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.00206	0.0241	CbGpPWpGaD
Niacin—SLC16A3—bone marrow—acquired immunodeficiency syndrome	0.00201	0.0166	CbGeAlD
Niacin—NNMT—brain—acquired immunodeficiency syndrome	0.00189	0.0156	CbGeAlD
Niacin—SLC16A1—retina—acquired immunodeficiency syndrome	0.00189	0.0156	CbGeAlD
Niacin—NNMT—lymph node—acquired immunodeficiency syndrome	0.00182	0.0151	CbGeAlD
Niacin—SLC16A3—lung—acquired immunodeficiency syndrome	0.00182	0.0151	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00175	0.0205	CbGpPWpGaD
Niacin—SLC16A3—nervous system—acquired immunodeficiency syndrome	0.00169	0.014	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00166	0.0194	CbGpPWpGaD
Niacin—SLC16A3—central nervous system—acquired immunodeficiency syndrome	0.00162	0.0134	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00158	0.0185	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0015	0.0175	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00133	0.0156	CbGpPWpGaD
Niacin—SLC16A1—digestive system—acquired immunodeficiency syndrome	0.00132	0.011	CbGeAlD
Niacin—SLC16A3—brain—acquired immunodeficiency syndrome	0.00129	0.0107	CbGeAlD
Niacin—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00127	0.0105	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00126	0.0148	CbGpPWpGaD
Niacin—SLC16A3—lymph node—acquired immunodeficiency syndrome	0.00125	0.0103	CbGeAlD
Niacin—HCAR2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00123	0.0144	CbGpPWpGaD
Niacin—SLC16A1—spinal cord—acquired immunodeficiency syndrome	0.00122	0.0101	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0012	0.0141	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00117	0.0136	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00116	0.0135	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00116	0.0135	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00114	0.0134	CbGpPWpGaD
Niacin—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.00114	0.00943	CbGeAlD
Niacin—HCAR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00113	0.0132	CbGpPWpGaD
Niacin—SLC16A1—lung—acquired immunodeficiency syndrome	0.00111	0.00915	CbGeAlD
Niacin—HCAR3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.0011	0.0128	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.0011	0.0128	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00108	0.0127	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00108	0.0126	CbGpPWpGaD
Niacin—SLC22A5—retina—acquired immunodeficiency syndrome	0.00108	0.00892	CbGeAlD
Niacin—HCAR3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00107	0.0125	CbGpPWpGaD
Niacin—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.00105	0.00865	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00102	0.012	CbGpPWpGaD
Niacin—SLC16A1—nervous system—acquired immunodeficiency syndrome	0.00102	0.00847	CbGeAlD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00102	0.0119	CbGpPWpGaD
Niacin—SLC16A1—central nervous system—acquired immunodeficiency syndrome	0.000986	0.00816	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000977	0.0114	CbGpPWpGaD
Niacin—SLCO2B1—lung—acquired immunodeficiency syndrome	0.000952	0.00787	CbGeAlD
Niacin—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000946	0.00783	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000927	0.0108	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000919	0.0108	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000919	0.0108	CbGpPWpGaD
Niacin—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.000881	0.00729	CbGeAlD
Niacin—HCAR2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000879	0.0103	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000871	0.0102	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000871	0.0102	CbGpPWpGaD
Niacin—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.000848	0.00702	CbGeAlD
Niacin—HCAR3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000834	0.00975	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000823	0.00963	CbGpPWpGaD
Niacin—QPRT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000813	0.00951	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000792	0.00927	CbGpPWpGaD
Niacin—SLC16A1—brain—acquired immunodeficiency syndrome	0.000783	0.00648	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00078	0.00913	CbGpPWpGaD
Niacin—QPRT—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000776	0.00908	CbGpPWpGaD
Niacin—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000765	0.00896	CbGpPWpGaD
Niacin—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000757	0.00626	CbGeAlD
Niacin—SLC16A1—lymph node—acquired immunodeficiency syndrome	0.000757	0.00626	CbGeAlD
Niacin—NNMT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000756	0.00884	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000751	0.00879	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000744	0.00871	CbGpPWpGaD
Niacin—SLC22A5—blood—acquired immunodeficiency syndrome	0.000721	0.00596	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000706	0.00826	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.0007	0.00819	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.0007	0.00819	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000699	0.00818	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000697	0.00815	CbGpPWpGaD
Niacin—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000695	0.00575	CbGeAlD
Niacin—QPRT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000691	0.00809	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000684	0.008	CbGpPWpGaD
Niacin—SLCO2B1—brain—acquired immunodeficiency syndrome	0.000674	0.00557	CbGeAlD
Niacin—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000668	0.00553	CbGeAlD
Niacin—HCAR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000667	0.0078	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000663	0.00776	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000663	0.00776	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000663	0.00775	CbGpPWpGaD
Niacin—QPRT—Disease—CCNT1—acquired immunodeficiency syndrome	0.00066	0.00772	CbGpPWpGaD
Niacin—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.000651	0.00538	CbGeAlD
Niacin—HCAR3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000648	0.00758	CbGpPWpGaD
Niacin—NNMT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000643	0.00752	CbGpPWpGaD
Niacin—SLC22A5—lung—acquired immunodeficiency syndrome	0.000632	0.00523	CbGeAlD
Niacin—HCAR3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000632	0.00739	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00063	0.00737	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000618	0.00723	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000597	0.00699	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000586	0.00686	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000554	0.00648	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000532	0.00623	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000505	0.0059	CbGpPWpGaD
Niacin—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000488	0.00404	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00048	0.00561	CbGpPWpGaD
Niacin—CYP2D6—blood—acquired immunodeficiency syndrome	0.000465	0.00385	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000455	0.00532	CbGpPWpGaD
Niacin—SLC22A5—brain—acquired immunodeficiency syndrome	0.000447	0.0037	CbGeAlD
Niacin—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000432	0.00358	CbGeAlD
Niacin—HCAR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000422	0.00494	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000421	0.00492	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000404	0.00472	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000404	0.00472	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.0004	0.00468	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000399	0.00467	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000395	0.00463	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000395	0.00463	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000383	0.00448	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000383	0.00448	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000382	0.00447	CbGpPWpGaD
Niacin—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000378	0.00312	CbGeAlD
Niacin—HCAR3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000375	0.00439	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000375	0.00439	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000369	0.00432	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000365	0.00427	CbGpPWpGaD
Niacin—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000364	0.00301	CbGeAlD
Niacin—HCAR3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000362	0.00424	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000359	0.0042	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000359	0.0042	CbGpPWpGaD
Niacin—QPRT—Disease—CXCR4—acquired immunodeficiency syndrome	0.000347	0.00406	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000346	0.00405	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00034	0.00398	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00034	0.00398	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000314	0.00367	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000311	0.00364	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000301	0.00352	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000296	0.00347	CbGpPWpGaD
Niacin—CYP2D6—brain—acquired immunodeficiency syndrome	0.000289	0.00239	CbGeAlD
Niacin—HCAR3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000285	0.00334	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000281	0.00329	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000281	0.00329	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000273	0.0032	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000271	0.00317	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.00027	0.00316	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000269	0.00315	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000259	0.00303	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000257	0.00301	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000255	0.00298	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000249	0.00292	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000246	0.00288	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000244	0.00285	CbGpPWpGaD
Niacin—QPRT—Disease—CCR5—acquired immunodeficiency syndrome	0.000238	0.00278	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000237	0.00277	CbGpPWpGaD
Niacin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.000667	CcSEcCtD
Niacin—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.000666	CcSEcCtD
Niacin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000666	CcSEcCtD
Niacin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000235	0.000665	CcSEcCtD
Niacin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000235	0.000665	CcSEcCtD
Niacin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.000661	CcSEcCtD
Niacin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000233	0.000661	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000233	0.00273	CbGpPWpGaD
Niacin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00066	CcSEcCtD
Niacin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00066	CcSEcCtD
Niacin—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.00066	CcSEcCtD
Niacin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.00066	CcSEcCtD
Niacin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.000657	CcSEcCtD
Niacin—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000657	CcSEcCtD
Niacin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000231	0.000656	CcSEcCtD
Niacin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000655	CcSEcCtD
Niacin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000231	0.000655	CcSEcCtD
Niacin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000231	0.000655	CcSEcCtD
Niacin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000652	CcSEcCtD
Niacin—Headache—Didanosine—acquired immunodeficiency syndrome	0.00023	0.000651	CcSEcCtD
Niacin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00065	CcSEcCtD
Niacin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000229	0.00065	CcSEcCtD
Niacin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.000649	CcSEcCtD
Niacin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000649	CcSEcCtD
Niacin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000229	0.000648	CcSEcCtD
Niacin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000646	CcSEcCtD
Niacin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000645	CcSEcCtD
Niacin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.000644	CcSEcCtD
Niacin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000644	CcSEcCtD
Niacin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000227	0.000642	CcSEcCtD
Niacin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000642	CcSEcCtD
Niacin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000641	CcSEcCtD
Niacin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000226	0.000641	CcSEcCtD
Niacin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00064	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000226	0.00264	CbGpPWpGaD
Niacin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000225	0.000639	CcSEcCtD
Niacin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000225	0.000638	CcSEcCtD
Niacin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000638	CcSEcCtD
Niacin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000636	CcSEcCtD
Niacin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000636	CcSEcCtD
Niacin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000634	CcSEcCtD
Niacin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000632	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.000632	CcSEcCtD
Niacin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000222	0.00063	CcSEcCtD
Niacin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000222	0.000629	CcSEcCtD
Niacin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.000629	CcSEcCtD
Niacin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.000628	CcSEcCtD
Niacin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000628	CcSEcCtD
Niacin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000627	CcSEcCtD
Niacin—Pain—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000624	CcSEcCtD
Niacin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.000623	CcSEcCtD
Niacin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00022	0.000623	CcSEcCtD
Niacin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.000622	CcSEcCtD
Niacin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00062	CcSEcCtD
Niacin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00062	CcSEcCtD
Niacin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.000619	CcSEcCtD
Niacin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000619	CcSEcCtD
Niacin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000218	0.000618	CcSEcCtD
Niacin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000218	0.000618	CcSEcCtD
Niacin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000617	CcSEcCtD
Niacin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000616	CcSEcCtD
Niacin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000615	CcSEcCtD
Niacin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.000615	CcSEcCtD
Niacin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000614	CcSEcCtD
Niacin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.000613	CcSEcCtD
Niacin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000612	CcSEcCtD
Niacin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000612	CcSEcCtD
Niacin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00061	CcSEcCtD
Niacin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000215	0.000608	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000608	CcSEcCtD
Niacin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000607	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000214	0.0025	CbGpPWpGaD
Niacin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000603	CcSEcCtD
Niacin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000601	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000212	0.00248	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000212	0.00248	CbGpPWpGaD
Niacin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.0006	CcSEcCtD
Niacin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000599	CcSEcCtD
Niacin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000599	CcSEcCtD
Niacin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000599	CcSEcCtD
Niacin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.000599	CcSEcCtD
Niacin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000211	0.000597	CcSEcCtD
Niacin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000597	CcSEcCtD
Niacin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000597	CcSEcCtD
Niacin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000595	CcSEcCtD
Niacin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000595	CcSEcCtD
Niacin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00021	0.000594	CcSEcCtD
Niacin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000592	CcSEcCtD
Niacin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000592	CcSEcCtD
Niacin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.00059	CcSEcCtD
Niacin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000589	CcSEcCtD
Niacin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000208	0.000589	CcSEcCtD
Niacin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000208	0.000589	CcSEcCtD
Niacin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000588	CcSEcCtD
Niacin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000208	0.000588	CcSEcCtD
Niacin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000587	CcSEcCtD
Niacin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000586	CcSEcCtD
Niacin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.000586	CcSEcCtD
Niacin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000584	CcSEcCtD
Niacin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000584	CcSEcCtD
Niacin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000581	CcSEcCtD
Niacin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000581	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00058	CcSEcCtD
Niacin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00058	CcSEcCtD
Niacin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000578	CcSEcCtD
Niacin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000577	CcSEcCtD
Niacin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000577	CcSEcCtD
Niacin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000203	0.000576	CcSEcCtD
Niacin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000203	0.000574	CcSEcCtD
Niacin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000573	CcSEcCtD
Niacin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000571	CcSEcCtD
Niacin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.000571	CcSEcCtD
Niacin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.00057	CcSEcCtD
Niacin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00057	CcSEcCtD
Niacin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00057	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000201	0.00235	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000201	0.00235	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000569	CcSEcCtD
Niacin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000201	0.000569	CcSEcCtD
Niacin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000201	0.000569	CcSEcCtD
Niacin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000568	CcSEcCtD
Niacin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0002	0.000567	CcSEcCtD
Niacin—Headache—Stavudine—acquired immunodeficiency syndrome	0.0002	0.000565	CcSEcCtD
Niacin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.0002	0.000565	CcSEcCtD
Niacin—SLC16A1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000199	0.00233	CbGpPWpGaD
Niacin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000564	CcSEcCtD
Niacin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000564	CcSEcCtD
Niacin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.000563	CcSEcCtD
Niacin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000198	0.000561	CcSEcCtD
Niacin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000198	0.00056	CcSEcCtD
Niacin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00056	CcSEcCtD
Niacin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00056	CcSEcCtD
Niacin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00056	CcSEcCtD
Niacin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000197	0.000557	CcSEcCtD
Niacin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000556	CcSEcCtD
Niacin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000196	0.000555	CcSEcCtD
Niacin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.000555	CcSEcCtD
Niacin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000552	CcSEcCtD
Niacin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000551	CcSEcCtD
Niacin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000549	CcSEcCtD
Niacin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000548	CcSEcCtD
Niacin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000548	CcSEcCtD
Niacin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000545	CcSEcCtD
Niacin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000545	CcSEcCtD
Niacin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000544	CcSEcCtD
Niacin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000544	CcSEcCtD
Niacin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000542	CcSEcCtD
Niacin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000541	CcSEcCtD
Niacin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000539	CcSEcCtD
Niacin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.000538	CcSEcCtD
Niacin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000538	CcSEcCtD
Niacin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000537	CcSEcCtD
Niacin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000537	CcSEcCtD
Niacin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000189	0.000536	CcSEcCtD
Niacin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000535	CcSEcCtD
Niacin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000534	CcSEcCtD
Niacin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000531	CcSEcCtD
Niacin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.00053	CcSEcCtD
Niacin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000186	0.000528	CcSEcCtD
Niacin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000527	CcSEcCtD
Niacin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000527	CcSEcCtD
Niacin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000524	CcSEcCtD
Niacin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000185	0.000523	CcSEcCtD
Niacin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000523	CcSEcCtD
Niacin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000523	CcSEcCtD
Niacin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000522	CcSEcCtD
Niacin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000522	CcSEcCtD
Niacin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000521	CcSEcCtD
Niacin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000521	CcSEcCtD
Niacin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000519	CcSEcCtD
Niacin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000517	CcSEcCtD
Niacin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000182	0.000516	CcSEcCtD
Niacin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00051	CcSEcCtD
Niacin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.00051	CcSEcCtD
Niacin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000508	CcSEcCtD
Niacin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000507	CcSEcCtD
Niacin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000507	CcSEcCtD
Niacin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000503	CcSEcCtD
Niacin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000502	CcSEcCtD
Niacin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000499	CcSEcCtD
Niacin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000499	CcSEcCtD
Niacin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000176	0.000499	CcSEcCtD
Niacin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000499	CcSEcCtD
Niacin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000498	CcSEcCtD
Niacin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.000495	CcSEcCtD
Niacin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000495	CcSEcCtD
Niacin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000494	CcSEcCtD
Niacin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000493	CcSEcCtD
Niacin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000491	CcSEcCtD
Niacin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000488	CcSEcCtD
Niacin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000487	CcSEcCtD
Niacin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000486	CcSEcCtD
Niacin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000485	CcSEcCtD
Niacin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000484	CcSEcCtD
Niacin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000482	CcSEcCtD
Niacin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000482	CcSEcCtD
Niacin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000482	CcSEcCtD
Niacin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00048	CcSEcCtD
Niacin—SLC16A1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000169	0.00198	CbGpPWpGaD
Niacin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000479	CcSEcCtD
Niacin—SLC16A1—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000168	0.00197	CbGpPWpGaD
Niacin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000473	CcSEcCtD
Niacin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000472	CcSEcCtD
Niacin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000467	CcSEcCtD
Niacin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000466	CcSEcCtD
Niacin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000466	CcSEcCtD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000164	0.00192	CbGpPWpGaD
Niacin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000464	CcSEcCtD
Niacin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000464	CcSEcCtD
Niacin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000164	0.000464	CcSEcCtD
Niacin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00046	CcSEcCtD
Niacin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00046	CcSEcCtD
Niacin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000458	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000161	0.00189	CbGpPWpGaD
Niacin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000457	CcSEcCtD
Niacin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000456	CcSEcCtD
Niacin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000451	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000159	0.00186	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000159	0.00186	CbGpPWpGaD
Niacin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000449	CcSEcCtD
Niacin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000445	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000157	0.00183	CbGpPWpGaD
Niacin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000443	CcSEcCtD
Niacin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000443	CcSEcCtD
Niacin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000438	CcSEcCtD
Niacin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000438	CcSEcCtD
Niacin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000436	CcSEcCtD
Niacin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000435	CcSEcCtD
Niacin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000434	CcSEcCtD
Niacin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000433	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000153	0.00179	CbGpPWpGaD
Niacin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000433	CcSEcCtD
Niacin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000432	CcSEcCtD
Niacin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000432	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000151	0.00176	CbGpPWpGaD
Niacin—QPRT—Disease—CD4—acquired immunodeficiency syndrome	0.000149	0.00175	CbGpPWpGaD
Niacin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000421	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000148	0.00174	CbGpPWpGaD
Niacin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000419	CcSEcCtD
Niacin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000417	CcSEcCtD
Niacin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000416	CcSEcCtD
Niacin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000415	CcSEcCtD
Niacin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000415	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000146	0.00171	CbGpPWpGaD
Niacin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000413	CcSEcCtD
Niacin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000413	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000145	0.0017	CbGpPWpGaD
Niacin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000409	CcSEcCtD
Niacin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000403	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000142	0.00166	CbGpPWpGaD
Niacin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000402	CcSEcCtD
Niacin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000402	CcSEcCtD
Niacin—QPRT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000142	0.00166	CbGpPWpGaD
Niacin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000396	CcSEcCtD
Niacin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000392	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000138	0.00161	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000137	0.00161	CbGpPWpGaD
Niacin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000388	CcSEcCtD
Niacin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000388	CcSEcCtD
Niacin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000385	CcSEcCtD
Niacin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000384	CcSEcCtD
Niacin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000383	CcSEcCtD
Niacin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000382	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000135	0.00158	CbGpPWpGaD
Niacin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000373	CcSEcCtD
Niacin—NNMT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000132	0.00154	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000132	0.00154	CbGpPWpGaD
Niacin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00037	CcSEcCtD
Niacin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00037	CcSEcCtD
Niacin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00037	CcSEcCtD
Niacin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000368	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000129	0.00151	CbGpPWpGaD
Niacin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000362	CcSEcCtD
Niacin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000356	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000126	0.00147	CbGpPWpGaD
Niacin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000353	CcSEcCtD
Niacin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000353	CcSEcCtD
Niacin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000351	CcSEcCtD
Niacin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000349	CcSEcCtD
Niacin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000333	CcSEcCtD
Niacin—SLC16A1—Hemostasis—ALB—acquired immunodeficiency syndrome	8.57e-05	0.001	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.4e-05	0.000983	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.36e-05	0.000978	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.35e-05	0.000977	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—acquired immunodeficiency syndrome	8.07e-05	0.000944	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.96e-05	0.000932	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.92e-05	0.000927	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.42e-05	0.000868	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—acquired immunodeficiency syndrome	6.95e-05	0.000813	CbGpPWpGaD
Niacin—Salicylic acid—ALB—acquired immunodeficiency syndrome	6.53e-05	1	CrCbGaD
Niacin—SLC16A3—Metabolism—ALB—acquired immunodeficiency syndrome	6.44e-05	0.000753	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.38e-05	0.000747	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	5.55e-05	0.00065	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.94e-05	0.000578	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	4.72e-05	0.000552	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.68e-05	0.000548	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—acquired immunodeficiency syndrome	3.48e-05	0.000407	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	9.68e-06	0.000113	CbGpPWpGaD
